Listed

Rockwell Medical, Inc.

RMTINasdaqCIK 1041024HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$17.8m, Q2 FY2026
Operating income−$1.1m, Q2 FY2026
Net income−$1.2m, Q2 FY2026
Rockwell Medical, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m23.8Revenue, Q3 FY2023, three months to 2023-09-30$23.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2024-11-12, accession 0001628280-24-046839.Report this figure22.1Revenue, Q4 FY2023, three months to 2023-12-31$22.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2025-03-20, accession 0001628280-25-013983. Derived: 12-month figure less the 9-month figure.Report this figure22.7Revenue, Q1 FY2024, three months to 2024-03-31$22.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-05-12, accession 0001628280-25-024434.Report this figure25.8Revenue, Q2 FY2024, three months to 2024-06-30$25.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-08-14, accession 0001041024-25-000011.Report this figure28.3Revenue, Q3 FY2024, three months to 2024-09-30$28.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure24.7Revenue, Q4 FY2024, three months to 2024-12-31$24.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-26, accession 0001628280-26-021186. Derived: 12-month figure less the 9-month figure.Report this figure18.9Revenue, Q1 FY2025, three months to 2025-03-31$18.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure16.1Revenue, Q2 FY2025, three months to 2025-06-30$16.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure15.9Revenue, Q3 FY2025, three months to 2025-09-30$15.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure18.3Revenue, Q4 FY2025, three months to 2025-12-31$18.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-03-26, accession 0001628280-26-021186. Derived: 12-month figure less the 9-month figure.Report this figure17.3Revenue, Q1 FY2026, three months to 2026-03-31$17.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure17.8Revenue, Q2 FY2026, three months to 2026-06-30$17.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure
Cost of revenue$m21.6Cost of revenue, Q3 FY2023, three months to 2023-09-30$21.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-12, accession 0001628280-24-046839.Report this figure19.2Cost of revenue, Q4 FY2023, three months to 2023-12-31$19.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-03-20, accession 0001628280-25-013983. Derived: 12-month figure less the 9-month figure.Report this figure19.6Cost of revenue, Q1 FY2024, three months to 2024-03-31$19.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-12, accession 0001628280-25-024434.Report this figure21.3Cost of revenue, Q2 FY2024, three months to 2024-06-30$21.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-14, accession 0001041024-25-000011.Report this figure22.1Cost of revenue, Q3 FY2024, three months to 2024-09-30$22.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure21.0Cost of revenue, Q4 FY2024, three months to 2024-12-31$21.0m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-26, accession 0001628280-26-021186. Derived: 12-month figure less the 9-month figure.Report this figure15.9Cost of revenue, Q1 FY2025, three months to 2025-03-31$15.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure13.6Cost of revenue, Q2 FY2025, three months to 2025-06-30$13.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure13.7Cost of revenue, Q3 FY2025, three months to 2025-09-30$13.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure14.5Cost of revenue, Q4 FY2025, three months to 2025-12-31$14.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-26, accession 0001628280-26-021186. Derived: 12-month figure less the 9-month figure.Report this figure14.4Cost of revenue, Q1 FY2026, three months to 2026-03-31$14.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure14.5Cost of revenue, Q2 FY2026, three months to 2026-06-30$14.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure
Gross profit$m2.2Gross profit, Q3 FY2023, three months to 2023-09-30$2.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-12, accession 0001628280-24-046839.Report this figure2.9Gross profit, Q4 FY2023, three months to 2023-12-31$2.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-20, accession 0001628280-25-013983. Derived: 12-month figure less the 9-month figure.Report this figure3.1Gross profit, Q1 FY2024, three months to 2024-03-31$3.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-12, accession 0001628280-25-024434.Report this figure4.6Gross profit, Q2 FY2024, three months to 2024-06-30$4.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-14, accession 0001041024-25-000011.Report this figure6.2Gross profit, Q3 FY2024, three months to 2024-09-30$6.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure3.6Gross profit, Q4 FY2024, three months to 2024-12-31$3.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-26, accession 0001628280-26-021186. Derived: 12-month figure less the 9-month figure.Report this figure3.0Gross profit, Q1 FY2025, three months to 2025-03-31$3.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure2.5Gross profit, Q2 FY2025, three months to 2025-06-30$2.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure2.3Gross profit, Q3 FY2025, three months to 2025-09-30$2.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure3.9Gross profit, Q4 FY2025, three months to 2025-12-31$3.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-26, accession 0001628280-26-021186. Derived: 12-month figure less the 9-month figure.Report this figure2.9Gross profit, Q1 FY2026, three months to 2026-03-31$2.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure3.2Gross profit, Q2 FY2026, three months to 2026-06-30$3.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure
Research and development$m0.5Research and development, Q3 FY2023, three months to 2023-09-30$494.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001628280-24-046839.Report this figure0.2Research and development, Q4 FY2023, three months to 2023-12-31$168.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-20, accession 0001628280-25-013983. Derived: 12-month figure less the 9-month figure.Report this figure0.0Research and development, Q1 FY2024, three months to 2024-03-31$18.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001628280-25-024434.Report this figure0.0Research and development, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001041024-25-000011.Report this figure0.0Research and development, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure0.0Research and development, Q4 FY2024, three months to 2024-12-31$1.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-26, accession 0001628280-26-021186. Derived: 12-month figure less the 9-month figure.Report this figure0.0Research and development, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001628280-25-024434.Report this figure0.0Research and development, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure0.0Research and development, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure0.0Research and development, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-26, accession 0001628280-26-021186. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Research and development, Q2 FY2026, three months to 2026-06-30$40.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure
Selling, general and administrative$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Operating income$m(1.7)Operating income, Q3 FY2023, three months to 2023-09-30−$1.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001628280-24-046839.Report this figure(0.5)Operating income, Q4 FY2023, three months to 2023-12-31−$547.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-20, accession 0001628280-25-013983. Derived: 12-month figure less the 9-month figure.Report this figure(1.3)Operating income, Q1 FY2024, three months to 2024-03-31−$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001628280-25-024434.Report this figure0.5Operating income, Q2 FY2024, three months to 2024-06-30$515.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001041024-25-000011.Report this figure1.9Operating income, Q3 FY2024, three months to 2024-09-30$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure(0.5)Operating income, Q4 FY2024, three months to 2024-12-31−$519.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021186. Derived: 12-month figure less the 9-month figure.Report this figure(1.4)Operating income, Q1 FY2025, three months to 2025-03-31−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure(1.3)Operating income, Q2 FY2025, three months to 2025-06-30−$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure(1.6)Operating income, Q3 FY2025, three months to 2025-09-30−$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure(0.4)Operating income, Q4 FY2025, three months to 2025-12-31−$398.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021186. Derived: 12-month figure less the 9-month figure.Report this figure(1.5)Operating income, Q1 FY2026, three months to 2026-03-31−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure(1.1)Operating income, Q2 FY2026, three months to 2026-06-30−$1.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure
Interest expense$m0.4Interest expense, Q3 FY2023, three months to 2023-09-30$411.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-14, accession 0001628280-23-038781.Report this figure1.1Interest expense, Q4 FY2023, three months to 2023-12-31$1.1m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-21, accession 0001628280-24-012572. Derived: 12-month figure less the 9-month figure.Report this figure0.4Interest expense, Q1 FY2024, three months to 2024-03-31$431.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-14, accession 0001628280-24-023056.Report this figure0.2Interest expense, Q2 FY2024, three months to 2024-06-30$232.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-14, accession 0001041024-25-000011.Report this figure0.3Interest expense, Q3 FY2024, three months to 2024-09-30$302.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure0.3Interest expense, Q4 FY2024, three months to 2024-12-31$289.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-26, accession 0001628280-26-021186. Derived: 12-month figure less the 9-month figure.Report this figure0.3Interest expense, Q1 FY2025, three months to 2025-03-31$277.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure0.3Interest expense, Q2 FY2025, three months to 2025-06-30$276.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure0.3Interest expense, Q3 FY2025, three months to 2025-09-30$285.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure0.3Interest expense, Q4 FY2025, three months to 2025-12-31$286.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-26, accession 0001628280-26-021186. Derived: 12-month figure less the 9-month figure.Report this figure0.3Interest expense, Q1 FY2026, three months to 2026-03-31$282.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure0.3Interest expense, Q2 FY2026, three months to 2026-06-30$281.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure
Income tax$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(1.9)Net income, Q3 FY2023, three months to 2023-09-30−$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001628280-24-046839.Report this figure(1.5)Net income, Q4 FY2023, three months to 2023-12-31−$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-20, accession 0001628280-25-013983. Derived: 12-month figure less the 9-month figure.Report this figure(1.7)Net income, Q1 FY2024, three months to 2024-03-31−$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure0.3Net income, Q2 FY2024, three months to 2024-06-30$343.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure1.7Net income, Q3 FY2024, three months to 2024-09-30$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure(0.8)Net income, Q4 FY2024, three months to 2024-12-31−$756.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021186. Derived: 12-month figure less the 9-month figure.Report this figure(1.5)Net income, Q1 FY2025, three months to 2025-03-31−$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure(1.5)Net income, Q2 FY2025, three months to 2025-06-30−$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure(1.8)Net income, Q3 FY2025, three months to 2025-09-30−$1.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure(0.6)Net income, Q4 FY2025, three months to 2025-12-31−$554.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-26, accession 0001628280-26-021186. Derived: 12-month figure less the 9-month figure.Report this figure(1.6)Net income, Q1 FY2026, three months to 2026-03-31−$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure(1.2)Net income, Q2 FY2026, three months to 2026-06-30−$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure
Diluted EPS$ per share(0.07)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001628280-24-046839.Report this figurenot reported(0.06)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0001628280-25-024434.Report this figure0.01Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001041024-25-000011.Report this figure0.04Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figurenot reported(0.04)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure(0.05)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001041024-25-000011.Report this figure(0.05)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figurenot reported(0.04)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figurenot reported
Basic EPS$ per share(0.07)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001628280-24-046839.Report this figurenot reported(0.06)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0001628280-25-024434.Report this figure0.01Basic EPS, Q2 FY2024, three months to 2024-06-30$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001041024-25-000011.Report this figure0.05Basic EPS, Q3 FY2024, three months to 2024-09-30$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figurenot reported(0.04)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure(0.48)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure(0.05)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figurenot reported(0.04)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.04 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure(0.34)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure

Balance sheet

Cash and equivalents$10.5m, Q2 FY2026
Long-term debt$7.2m, Q2 FY2026
Shareholders' equity$35.1m, Q2 FY2026
Rockwell Medical, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m7.8Cash and equivalents, Q3 FY2023, at 2023-09-30$7.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-14, accession 0001628280-23-038781.Report this figure9.0Cash and equivalents, FY2023, at 2023-12-31$9.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-20, accession 0001628280-25-013983.Report this figure6.6Cash and equivalents, Q1 FY2024, at 2024-03-31$6.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001628280-24-023056.Report this figure11.9Cash and equivalents, Q2 FY2024, at 2024-06-30$11.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-08, accession 0001628280-24-035859.Report this figure12.3Cash and equivalents, Q3 FY2024, at 2024-09-30$12.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001628280-24-046839.Report this figure15.7Cash and equivalents, FY2024, at 2024-12-31$15.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-26, accession 0001628280-26-021186.Report this figure11.4Cash and equivalents, Q1 FY2025, at 2025-03-31$11.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001628280-25-024434.Report this figure12.5Cash and equivalents, Q2 FY2025, at 2025-06-30$12.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001041024-25-000011.Report this figure13.6Cash and equivalents, Q3 FY2025, at 2025-09-30$13.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure10.7Cash and equivalents, FY2025, at 2025-12-31$10.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure9.6Cash and equivalents, Q1 FY2026, at 2026-03-31$9.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure10.5Cash and equivalents, Q2 FY2026, at 2026-06-30$10.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure
Current assets$m28.2Current assets, Q3 FY2023, at 2023-09-30$28.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001628280-23-038781.Report this figure28.8Current assets, FY2023, at 2023-12-31$28.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-20, accession 0001628280-25-013983.Report this figure26.7Current assets, Q1 FY2024, at 2024-03-31$26.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001628280-24-023056.Report this figure29.8Current assets, Q2 FY2024, at 2024-06-30$29.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001628280-24-035859.Report this figure34.2Current assets, Q3 FY2024, at 2024-09-30$34.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001628280-24-046839.Report this figure37.0Current assets, FY2024, at 2024-12-31$37.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-26, accession 0001628280-26-021186.Report this figure33.0Current assets, Q1 FY2025, at 2025-03-31$33.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001628280-25-024434.Report this figure31.6Current assets, Q2 FY2025, at 2025-06-30$31.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001041024-25-000011.Report this figure37.5Current assets, Q3 FY2025, at 2025-09-30$37.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure38.2Current assets, FY2025, at 2025-12-31$38.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure36.9Current assets, Q1 FY2026, at 2026-03-31$36.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure36.4Current assets, Q2 FY2026, at 2026-06-30$36.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure
Total assets$m52.6Total assets, Q3 FY2023, at 2023-09-30$52.6m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001628280-23-038781.Report this figure52.2Total assets, FY2023, at 2023-12-31$52.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-20, accession 0001628280-25-013983.Report this figure50.7Total assets, Q1 FY2024, at 2024-03-31$50.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001628280-24-023056.Report this figure53.0Total assets, Q2 FY2024, at 2024-06-30$53.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001628280-24-035859.Report this figure57.1Total assets, Q3 FY2024, at 2024-09-30$57.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001628280-24-046839.Report this figure59.2Total assets, FY2024, at 2024-12-31$59.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-26, accession 0001628280-26-021186.Report this figure54.0Total assets, Q1 FY2025, at 2025-03-31$54.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001628280-25-024434.Report this figure52.6Total assets, Q2 FY2025, at 2025-06-30$52.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001041024-25-000011.Report this figure57.5Total assets, Q3 FY2025, at 2025-09-30$57.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure57.1Total assets, FY2025, at 2025-12-31$57.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure57.4Total assets, Q1 FY2026, at 2026-03-31$57.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure56.5Total assets, Q2 FY2026, at 2026-06-30$56.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure
Current liabilities$m21.4Current liabilities, Q3 FY2023, at 2023-09-30$21.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001628280-23-038781.Report this figure16.6Current liabilities, FY2023, at 2023-12-31$16.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-20, accession 0001628280-25-013983.Report this figure14.9Current liabilities, Q1 FY2024, at 2024-03-31$14.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001628280-24-023056.Report this figure14.9Current liabilities, Q2 FY2024, at 2024-06-30$14.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001628280-24-035859.Report this figure14.2Current liabilities, Q3 FY2024, at 2024-09-30$14.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001628280-24-046839.Report this figure14.1Current liabilities, FY2024, at 2024-12-31$14.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-26, accession 0001628280-26-021186.Report this figure11.2Current liabilities, Q1 FY2025, at 2025-03-31$11.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001628280-25-024434.Report this figure10.9Current liabilities, Q2 FY2025, at 2025-06-30$10.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001041024-25-000011.Report this figure9.6Current liabilities, Q3 FY2025, at 2025-09-30$9.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure9.6Current liabilities, FY2025, at 2025-12-31$9.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure9.9Current liabilities, Q1 FY2026, at 2026-03-31$9.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure11.2Current liabilities, Q2 FY2026, at 2026-06-30$11.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure
Total liabilities$m31.1Total liabilities, Q3 FY2023, at 2023-09-30$31.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001628280-23-038781.Report this figure30.9Total liabilities, FY2023, at 2023-12-31$30.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-20, accession 0001628280-25-013983.Report this figure30.1Total liabilities, Q1 FY2024, at 2024-03-31$30.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001628280-24-023056.Report this figure29.5Total liabilities, Q2 FY2024, at 2024-06-30$29.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001628280-24-035859.Report this figure27.9Total liabilities, Q3 FY2024, at 2024-09-30$27.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001628280-24-046839.Report this figure26.6Total liabilities, FY2024, at 2024-12-31$26.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-26, accession 0001628280-26-021186.Report this figure22.4Total liabilities, Q1 FY2025, at 2025-03-31$22.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001628280-25-024434.Report this figure22.2Total liabilities, Q2 FY2025, at 2025-06-30$22.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001041024-25-000011.Report this figure20.5Total liabilities, Q3 FY2025, at 2025-09-30$20.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure20.2Total liabilities, FY2025, at 2025-12-31$20.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure21.6Total liabilities, Q1 FY2026, at 2026-03-31$21.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure21.4Total liabilities, Q2 FY2026, at 2026-06-30$21.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure
Long-term debt$m3.3Long-term debt, Q3 FY2023, at 2023-09-30$3.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2023-11-14, accession 0001628280-23-038781.Report this figure8.3Long-term debt, FY2023, at 2023-12-31$8.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2025-03-20, accession 0001628280-25-013983.Report this figure8.3Long-term debt, Q1 FY2024, at 2024-03-31$8.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-05-14, accession 0001628280-24-023056.Report this figure8.3Long-term debt, Q2 FY2024, at 2024-06-30$8.3m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-08-08, accession 0001628280-24-035859.Report this figure8.4Long-term debt, Q3 FY2024, at 2024-09-30$8.4m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2024-11-12, accession 0001628280-24-046839.Report this figure8.5Long-term debt, FY2024, at 2024-12-31$8.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-26, accession 0001628280-26-021186.Report this figure8.6Long-term debt, Q1 FY2025, at 2025-03-31$8.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-05-12, accession 0001628280-25-024434.Report this figure8.6Long-term debt, Q2 FY2025, at 2025-06-30$8.6m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-08-14, accession 0001041024-25-000011.Report this figure8.7Long-term debt, Q3 FY2025, at 2025-09-30$8.7m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure8.8Long-term debt, FY2025, at 2025-12-31$8.8m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure8.2Long-term debt, Q1 FY2026, at 2026-03-31$8.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure7.2Long-term debt, Q2 FY2026, at 2026-06-30$7.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure
Current portion of debt$m5.6Current portion of debt, Q3 FY2023, at 2023-09-30$5.6m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2023-11-14, accession 0001628280-23-038781.Report this figure0.0Current portion of debt, FY2023, at 2023-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-K filed 2024-03-21, accession 0001628280-24-012572.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reported0.0Current portion of debt, FY2025, at 2025-12-31$0. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure0.7Current portion of debt, Q1 FY2026, at 2026-03-31$707.0k. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure1.8Current portion of debt, Q2 FY2026, at 2026-06-30$1.8m. XBRL concept us-gaap:LongTermDebtCurrent. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure
Shareholders' equity$m21.5Shareholders' equity, Q3 FY2023, at 2023-09-30$21.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001628280-24-046839.Report this figure21.3Shareholders' equity, FY2023, at 2023-12-31$21.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-26, accession 0001628280-26-021186.Report this figure20.6Shareholders' equity, Q1 FY2024, at 2024-03-31$20.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure23.5Shareholders' equity, Q2 FY2024, at 2024-06-30$23.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure29.1Shareholders' equity, Q3 FY2024, at 2024-09-30$29.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure32.6Shareholders' equity, FY2024, at 2024-12-31$32.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure31.5Shareholders' equity, Q1 FY2025, at 2025-03-31$31.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure30.4Shareholders' equity, Q2 FY2025, at 2025-06-30$30.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure37.0Shareholders' equity, Q3 FY2025, at 2025-09-30$37.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure37.0Shareholders' equity, FY2025, at 2025-12-31$37.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure35.9Shareholders' equity, Q1 FY2026, at 2026-03-31$35.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure35.1Shareholders' equity, Q2 FY2026, at 2026-06-30$35.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure

Cash flow

Operating cash flow$2.1m, Q2 FY2026
Capital expenditure$617.0k, Q2 FY2026
Rockwell Medical, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(3,753)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001628280-24-046839. Derived: 9-month figure less the 6-month figure.Report this figure(43.0)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$43.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-20, accession 0001628280-25-013983. Derived: 12-month figure less the 9-month figure.Report this figure(2,380)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$2.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001628280-25-024434.Report this figure1,442Operating cash flow, Q2 FY2024, three months to 2024-06-30$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001041024-25-000011. Derived: 6-month figure less the 3-month figure.Report this figure4,275Operating cash flow, Q3 FY2024, three months to 2024-09-30$4.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001628280-25-051290. Derived: 9-month figure less the 6-month figure.Report this figure865Operating cash flow, Q4 FY2024, three months to 2024-12-31$865.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001628280-26-021186. Derived: 12-month figure less the 9-month figure.Report this figure(3,487)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$3.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure1,844Operating cash flow, Q2 FY2025, three months to 2025-06-30$1.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001628280-26-056461. Derived: 6-month figure less the 3-month figure.Report this figure(1,307)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$1.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001628280-25-051290. Derived: 9-month figure less the 6-month figure.Report this figure2,291Operating cash flow, Q4 FY2025, three months to 2025-12-31$2.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-26, accession 0001628280-26-021186. Derived: 12-month figure less the 9-month figure.Report this figure(167)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$167.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure2,080Operating cash flow, Q2 FY2026, three months to 2026-06-30$2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001628280-26-056461. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$knot reported43.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$43.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2025-03-20, accession 0001628280-25-013983. Derived: 12-month figure less the 9-month figure.Report this figure139Capital expenditure, Q1 FY2024, three months to 2024-03-31$139.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-05-12, accession 0001628280-25-024434.Report this figure286Capital expenditure, Q2 FY2024, three months to 2024-06-30$286.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-08-14, accession 0001041024-25-000011. Derived: 6-month figure less the 3-month figure.Report this figure191Capital expenditure, Q3 FY2024, three months to 2024-09-30$191.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-11-12, accession 0001628280-25-051290. Derived: 9-month figure less the 6-month figure.Report this figure395Capital expenditure, Q4 FY2024, three months to 2024-12-31$395.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-03-26, accession 0001628280-26-021186. Derived: 12-month figure less the 9-month figure.Report this figure63.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$63.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure164Capital expenditure, Q2 FY2025, three months to 2025-06-30$164.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-08-13, accession 0001628280-26-056461. Derived: 6-month figure less the 3-month figure.Report this figure229Capital expenditure, Q3 FY2025, three months to 2025-09-30$229.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-11-12, accession 0001628280-25-051290. Derived: 9-month figure less the 6-month figure.Report this figure86.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$86.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-03-26, accession 0001628280-26-021186. Derived: 12-month figure less the 9-month figure.Report this figure425Capital expenditure, Q1 FY2026, three months to 2026-03-31$425.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure617Capital expenditure, Q2 FY2026, three months to 2026-06-30$617.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-08-13, accession 0001628280-26-056461. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)3.96m, Q2 FY2026
Rockwell Medical, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares18.5Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3018,463,673 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001628280-23-038781.Report this figure18.4Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3118,359,940 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0001628280-24-023056.Report this figure18.5Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3018,496,640 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001628280-24-035859.Report this figure27.5Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3027,521,088 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001628280-24-046839.Report this figure29.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3129,327,204 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001628280-25-024434.Report this figure32.0Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3032,033,776 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001041024-25-000011.Report this figure32.4Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3032,420,168 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure34.1Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3134,107,640 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure3.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-303,431,130 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure36.0Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3036,024,940 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001628280-25-051290.Report this figure39.4Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3139,418,302 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001628280-26-031663.Report this figure4.0Diluted shares (weighted), Q2 FY2026, three months to 2026-06-303,958,568 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure

Shares outstanding: 4.03mShares outstanding, period not labelled, at 2026-08-104,030,465 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001628280-26-056461.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. Listed shows no prices and gives no investment advice.